First targeted therapy for rare mutation of gastrointestinal stromal tumors
The U.S. Food and Drug Administration (FDA) recently announced the approval of Blueprint Medicines Corporation’s avapritinib (Ayvakit) for the treatment…
Clinical Topics
Deaths from coronavirus rise
In the past 24 hours, news coverage of the coronavirus in Wuhan, China has become more and more rampant. I…
First coronavirus patient identified in U.S.
On the heels of today’s earlier post regarding the increase mortality rates in Wuhan, China from the coronavirus, The New York…
New findings from the American Cancer Society on reduced cancer mortality rates
Based on new findings from a 2020 American Cancer Society report, mortality rates from cancer have declined by 29% between…
First FDA-approved treatment for preventing Ebola virus
In late December 2019, the U.S. Food and Drug Administration (FDA) announced the approval of Merck’s Ervebo, the first FDA-approved…